680
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Adverse Clinical Outcomes Attributable to Socioeconomic and Ethnic Disparities Among People with Type 2 Diabetes in New Zealand Between 1994–2018: A Multiple Linked Cohort Study

ORCID Icon, ORCID Icon, , , , , , , , & show all
Pages 511-523 | Received 10 Jan 2023, Accepted 17 Apr 2023, Published online: 01 May 2023

References

  • Singh GK, Siahpush M, Azuine RE, Williams SD. Increasing Area deprivation and socioeconomic inequalities in heart disease, stroke, and cardiovascular disease mortality among working age populations, United States, 1969–2011. Int J MCH AIDS. 2015;3(2):119–133.
  • Metcalf PA, Scragg RR, Schaaf D, Dyall L, Black PN, Jackson RT. Comparison of different markers of socioeconomic status with cardiovascular disease and diabetes risk factors in the diabetes, heart and health survey. N Z Med J. 2008;121(1269):45–56.
  • Mackenbach JP, Bakker MJ. European network on interventions and policies to reduce inequalities in health: tackling socioeconomic inequalities in health: analysis of European experiences. Lancet. 2003;362(9393):1409–1414. doi:10.1016/S0140-6736(03)14639-9
  • Ezzatvar Y, Ramirez-Velez R, Izquierdo M, Garcia-Hermoso A. Racial differences in all-cause mortality and future complications among people with diabetes: a systematic review and meta-analysis of data from more than 2.4 million individuals. Diabetologia. 2021;64(11):2389–2401. doi:10.1007/s00125-021-05554-9
  • New Zealand Ministry of Health. Reducing Inequalities in Health. Available from: https://www.health.govt.nz/system/files/documents/publications/reducineqal.pdf. Accessed April 21, 2023.
  • Simmons D, Fleming CE, Cutfield R, Patel A, Innes J, Wellingham J. The diabetes care support service for general practitioners in Auckland. N Z Med J. 1997;110(1038):48–50.
  • Atkinson J, Salmond C, Crampton P. NZDep2013 Index of Deprivation. Available from: https://www.otago.ac.nz/wellington/otago069936.pdf. Accessed April 21, 2023.
  • Mansournia MA, Altman DG. Population attributable fraction. BMJ. 2018;360:k757. doi:10.1136/bmj.k757
  • White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–399. doi:10.1002/sim.4067
  • Maru S, Koch GG, Stender M, et al. Antidiabetic drugs and heart failure risk in patients with type 2 diabetes in the U.K. Primary care setting. Diabetes Care. 2005;28(1):20–26. doi:10.2337/diacare.28.1.20
  • Yu D, Zhao Z, Osuagwu UL, et al. Ethnic differences in mortality and hospital admission rates between Maori, Pacific, and European New Zealanders with type 2 diabetes between 1994 and 2018: a retrospective, population-based, longitudinal cohort study. Lancet Glob Health. 2021;9(2):e209–e217. doi:10.1016/S2214-109X(20)30412-5
  • Herbert A, Gilbert R, Cottrell D, Li L. Causes of death up to 10 years after admissions to hospitals for self-inflicted, drug-related or alcohol-related, or violent injury during adolescence: a retrospective, nationwide, cohort study. Lancet. 2017;390(10094):577–587. doi:10.1016/S0140-6736(17)31045-0
  • Daly B, Toulis KA, Thomas N, et al. Increased risk of ischemic heart disease, hypertension, and type 2 diabetes in women with previous gestational diabetes mellitus, a target group in general practice for preventive interventions: a population-based cohort study. PLoS Med. 2018;15(1):e1002488. doi:10.1371/journal.pmed.1002488
  • Havranek E, Mujahid M, Barr D, et al. Social determinants of risk and outcomes for cardiovascular disease: a scientific statement from the American heart association. Circulation. 2015;132(9):873–898. doi:10.1161/CIR.0000000000000228
  • Tatulashvili S, Fagherazzi G, Dow C, Cohen R, Fosse S, Bihan H. Socioeconomic inequalities and type 2 diabetes complications: a systematic review. Diabetes Metab. 2020;46(2):89–99. doi:10.1016/j.diabet.2019.11.001
  • Grintsova O, Maier W, Mielck A. Inequalities in health care among patients with type 2 diabetes by individual socio-economic status (SES) and regional deprivation: a systematic literature review. Int J Equity Health. 2014;13:43–9276. doi:10.1186/1475-9276-13-43
  • Jansen RM, Sundborn G, Cutfield R, Yu D, Simmons D. Ethnic inequity in diabetes outcomes-inaction in the face of need. N Z Med J. 2020;133(1525):8–10.
  • Adler NE, Newman K. Socioeconomic disparities in health: pathways and policies. Health Aff. 2002;21(2):60–76. doi:10.1377/hlthaff.21.2.60
  • Monsivais P, Amiri S, Denne J, Amram O. Area deprivation amplifies racial inequities in premature mortality: analysis of 242,667 deaths in Washington State, USA 2011–15. Health Place. 2020;61:102261. doi:10.1016/j.healthplace.2019.102261
  • Saint-Jacques N, Dewars R, Cui Y, Parker L, Dummer T. Premature mortality due to social and material deprivation in Nova Scotia, Canada. Int J Equity Health. 2014;13(1):94. doi:10.1186/s12939-014-0094-2
  • Chaturvedi N. Ethnic differences in cardiovascular disease. Heart. 2003;89(6):681–686. doi:10.1136/heart.89.6.681
  • Saeed S, Kanaya AM, Bennet L, Nilsson PM. Cardiovascular risk assessment in South and Middle-East Asians living in the Western countries. Pak J Med Sci. 2020;36(7):1719–1725. doi:10.12669/pjms.36.7.3292
  • Ueshima H, Sewa A, Miura K, et al. Cardiovascular disease and risk factors in Asia: a selected review. Circulation. 2008;118(25):2702–2709. doi:10.1161/CIRCULATIONAHA.108.790048
  • Thompson C, Simmons D, Collins J, Cecil A. Predisposition to nephropathy in Polynesians is associated with family history of renal disease, not diabetes mellitus. Diabetic Med. 2001;18(1):40–46. doi:10.1046/j.1464-5491.2001.00406.x
  • Whitehead J, Pearson AL, Lawrenson R, Atatoa-Carr P. Spatial equity and realised access to healthcare - a geospatial analysis of general practitioner enrolments in Waikato, New Zealand. Rural Remote Health. 2019;19(4):5349. doi:10.22605/RRH5349
  • Reddy R, Welch D, Lima I, Thorne P, Nosa V. Identifying hearing care access barriers among older Pacific Island people in New Zealand: a qualitative study. BMJ Open. 2019;9(8):e029007–2019. doi:10.1136/bmjopen-2019-029007
  • Robinson T, Simmons D, Scott D, et al. Ethnic differences in type 2 diabetes care and outcomes in Auckland: a multiethnic community in New Zealand. N Z Med J. 2006;119(1235):U1997.
  • Yu D, Cai Y, Osuagwu UL, et al. Metabolic profiles of Maori, Pacific, and European New Zealanders with type 2 diabetes over 25 years. Diabetes Care. 2021;44:e183–e185. doi:10.2337/dc21-1255
  • Lim S, Chellumuthi C, Crook N, Rush E, Simmons D. Low prevalence of retinopathy, but high prevalence of nephropathy among Maori with newly diagnosed diabetes-Te Wai o Rona: diabetes prevention strategy. Diabetes Res Clin Pract. 2008;80(2):271–274. doi:10.1016/j.diabres.2007.12.018
  • Simmons D, Rush E, Crook N. Prevalence of undiagnosed diabetes, impaired glucose tolerance, and impaired fasting glucose among Maori in Te Wai o Rona: diabetes prevention strategy. N Z Med J. 2009;122(1288):30–38.
  • Axelsson P, Kukutai T, Kippen R. The field of Indigenous health and the role of colonisation and history. J Popul Res. 2016;33:1–7. doi:10.1007/s12546-016-9163-2
  • Reid P, Cormack D, Paine S. Colonial histories, racism and health-the experience of Māori and Indigenous peoples. Public Health. 2019;172:119–124. doi:10.1016/j.puhe.2019.03.027
  • Daniel M, Cargo M, Marks E, et al. Rating health and social indicators for use with indigenous communities: a tool for balancing cultural and scientific utility. Soc Indic Res. 2009;94(2):241–256. doi:10.1007/s11205-008-9420-7
  • Risch N, Burchard E, Ziv E, Tang H. Categorization of humans in biomedical research: genes, race and disease. Genome Biol. 2002;3(7):comment2007–2002. doi:10.1186/gb-2002-3-7-comment2007
  • Sundborn G, Metcalf P, Scragg R, et al. Ethnic differences in the prevalence of new and known diabetes mellitus, impaired glucose tolerance, and impaired fasting glucose. Diabetes Heart and Health Survey (DHAH) 2002–2003, Auckland New Zealand. N Z Med J. 2007;120(1257):U2607.
  • Coppell K, Mann J, Williams S, et al. Prevalence of diagnosed and undiagnosed diabetes and prediabetes in New Zealand: findings from the 2008/09 Adult Nutrition Survey. N Z Med J. 2013;126(1370):23–42.
  • PHARMAC. Decision to fund two new medicines for type 2 diabetes - Amended with Q&A. Available from: https://pharmac.govt.nz/news-and-resources/consultations-and-decisions/decision-to-fund-two-new-medicines-for-type-2-diabetes/. Accessed April 21, 2023.
  • Tan J, Manley P, Gamble G, et al. DEFEND investigators: long-term effectiveness of a community-based model of care in Maori and Pacific patients with type 2 diabetes and chronic kidney disease: a 4-year follow up of the DElay Future End Stage Nephropathy due to Diabetes (DEFEND) study. Intern Med J. 2015;45(8):843–849. doi:10.1111/imj.12788